Celling Biosciences is a biotech company focused on the science, research and development of autologous cellular therapy. Celling developed the first system on the market that allows a user to regulate and select a desired cell type through a patented collection window and integrated ultra-filtration system.

Celling Biosciences is dedicated to the scientific understanding and therapeutic application of autologous cell therapy. Celling is fulfilling the promise that autologous cell therapy will bring physicians new clinical approaches and treatment options to address patient needs across a wide spectrum of preventative and regenerative medicine.

Technologies developed by Celling Biosciences collect, process and deliver autologous cells to the patient at the point of care. The use of the patient’s own cells to promote healing provides a way of accelerating the body’s natural healing process.

The ART PLUS Family of products is the only integrated ultra-filtration system on the market that allows for the processing of bone marrow, peripheral blood and growth factors at the point of care.